Page results
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
The Sickle Cell Society (SCS) and the UK Thalassaemia Society (UKTS) have worked in partnership with the NHS sickle cell and thalassaemia (SCT) screening programme to engage with communities less likely to access health information through usual NHS channels. The societies provide feedback from people that share the same population background or have experience of the condition and to feed into the programme updates and improvements.
-
A combination of two drugs could be an effective treatment for the debilitating disease lupus, according to preliminary evidence from a UCLH led trial.
-
A patient with motor neurone disease was able to control a computer just by using his thoughts following the UK’s first Neuralink implant surgery at UCLH’s National Hospital for Neurology and Neurosurgery (NHNN) in October 2025.
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
In a joint public appearance, the trio, who are Honorary Patrons of Teenage Cancer Trust, visited the ward to meet young patients and thank staff for their work.
-
Information about the new government support available to help people pay their energy bills.
-
The Royal London Hospital for Integrated Medicine (RLHIM) is a centre for evidence-based practice, education and research, specialising in chronic and complex medical conditions. Our mission is to provide a person-centred, holistic approach, including self-care, in order to help people with chronic and complex medical conditions live well and feel better. Our approach considers the whole person and their environment in the quest for optimal health and wellbeing. In order to achieve this, we provide a combination of lifestyle strategies, medical, physical and psychological treatment, as well as advice on safe and appropriate use of complementary therapies. We also deliver and encourage self-care approaches which can continue to be used by patients after discharge. All RLHIM services are outpatient-based and are staffed by experienced healthcare professionals.
-
Every five years, a national Peer Review process casts a supportive but critical eye over red cell services across the UK.
File results
-
FOI/2024/0561 - Gender reassignment and/or transgender policies, mixed/same sex accommodation and Equality Impact Assessments (EIA)
-
FOI/2024/0560 - Coroners' Prevention of Future Deaths Reports
-
FOI/2024/0559 - Surgical Robots purchase/ simulators/ procedures 2019-2024
-
FOI/2024/0455 - Information Governance structure
-
FOI/2024/0541 - Healthcare-associated infections (HAIs) 2022-2024
-
FOI/2024/0537 - SHO doctor shifts covered by physician associates December 2023-May 2024
-
FOI/2024/0534 - NHS staff absence rates
-
FOI/2024/0542 - Single-use medical items usage at Trust
-
FOI/2024/0450 - Trust-wide obesity and weight management strategy
-
FOI/2024/0440 - Patient reported outcome measures (PROMs) in oncology